For instance, nutlin‐3 (a p53/MDM2 antagonist) has been found to target the p53/MDM2 interaction and activate the p53 pathway in both chemosensitive and chemoresistant NB cells with wild‐type p53.214. The gene discussed is TP53; the disease is neuroblastoma.